I

n 2010, an attorney jumped in front of a train and his widow claims his suicide should be blamed on GlaxoSmithKline for failing to update the warnings on its Paxil antidepressant.

So Wendy Dolin later filed a lawsuit seeking $12 million on the grounds that the drug maker knew its pill puts adults at risk for suicide. Yet her husband had taken a generic version of the drug at the time he committed suicide, and this is one of a few intriguing elements in a closely watched case that is under way in a Chicago federal courtroom.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy